Abbott Laboratories (ABT) Revenue — Quarter Ended Mar 31, 2026
Revenue declined from the prior quarter but rose from the same quarter a year earlier. The sequential decrease interrupted a series of quarterly gains.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue declined from the prior quarter but rose from the same quarter a year earlier. The sequential decrease interrupted a series of quarterly gains.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.2B
Revenue reported for this quarter.
Quarter-over-quarter
-2.6%
Change from the immediately preceding quarter.
Year-over-year
+7.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$45.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $11.1B | +7.4% |
| Sep 30, 2025 | $11.4B | +6.9% |
| Dec 31, 2025 | $11.5B | +4.4% |
| Mar 31, 2026 | $11.2B | +7.8% |
Revenue performance
The quarter's revenue was lower than the preceding period, marking a departure from the recent growth trajectory. Year-over-year, revenue remained higher.
Quarterly comparison
When measured against the immediately preceding quarter, revenue fell. In contrast, compared with the same period one year ago, revenue increased.
What to watch
It will be important to see if the sequential decline continues or reverses in coming quarters.